ABEONA THERAPEUTICS INC. 8-K

What Happened

• On May 13, 2026, Abeona Therapeutics, Inc. filed an 8-K (Item 2.02) announcing that it issued a press release reporting financial results for the quarter ended March 31, 2026.
• The company also posted an “Q1 2026 Results and Pipeline Update” presentation on its investor site (investors.abeonatherapeutics.com) that management will use on the upcoming earnings conference call. The press release and presentation are furnished as Exhibits 99.1 and 99.2 to the 8-K.

Key Details

• Filing date: May 13, 2026 (8-K covering Item 2.02 and Item 9.01).
• Reporting period: Quarter ended March 31, 2026.
• Materials furnished: Press release (Exhibit 99.1) and Earnings Presentation titled “Q1 2026 Results and Pipeline Update” (Exhibit 99.2).
• Presentation posted on the company’s investor relations website and will be used during the earnings conference call.

Why It Matters

• This 8-K signals that Abeona has released its latest quarterly earnings and a pipeline update; investors should review the press release and presentation for specifics on revenue, expenses, cash position, and any program updates or milestones.
• The materials may affect near-term investor decisions (trading, analyst coverage, or follow-up questions on the earnings call), so retail investors should read the exhibits and listen to the company’s call for full context and any guidance or developments.